Steve C Cullen
Inventor
Stats
- 0 US patents issued
- 6 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 6 US Applications Filed
- 20 Total Citation Count
- May 31, 2022 Most Recent Filing
- Dec 9, 2015 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| ABBVIE INC. | 2
| 2015
|
Inventor Addresses
| Address | Duration |
|---|---|
| Lake Vill, IL, US | Jun 09, 16 - Nov 24, 16 |
| Lake Villa, IL, US | May 16, 19 - Feb 22, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 6 |
| C07D: | HETEROCYCLIC COMPOUNDS | 6 |
| C07K: | PEPTIDES | 2 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0058,450 | 2024 | BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same | 0 |
| 2020/0246,460 | 2020 | BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same | 1 |
| 2020/0239,553 | 2020 | BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same | 1 |
| 2019/0142,941 | 2019 | BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same | 1 |
| 2016/0339,117 | 2016 | BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same | 3 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.